Award
National Eye Institute 1R43EY036347-01
Sustained cysteamine delivery by nanobarrier contact lenses to replace 8xdaily drops with a daily disposable lens
Recipient
DIOPTER TECHNOLOGIES, INC.
Award Amount
$332,179.00
Ceiling
$332,179.00
Awarded
August 15, 2024
Identifier
1R43EY036347-01
Award for developing sustained-release contact lenses for cysteamine delivery to replace frequent eye drops, funded by the National Eye Institute with a project duration of two years.
Description
The project involves developing contact lenses for cysteamine delivery to treat cystinosis. The project aims to replace eye drops with a sustained-release contact lens, including GMP manufacturing and potency testing. The project duration is from September 1, 2024, to August 31, 2026, and is part of a Phase I clinical study plan.